Rhythm Pharmaceuticals Inc.

About Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc. is a pioneering biopharmaceutical company dedicated to transforming the treatment landscape for patients with rare genetic disorders of obesity. Our mission is to develop innovative therapies that address the unmet medical needs of individuals suffering from these conditions, ultimately improving their quality of life.

Founded on the principles of scientific excellence and patient-centricity, we leverage cutting-edge research and advanced technologies to discover and develop novel therapeutics. Our lead product candidate, setmelanotide, is designed to target specific pathways in the brain that regulate appetite and energy expenditure, offering hope to patients with genetic obesity syndromes.

At Rhythm, we are committed to conducting rigorous clinical trials to validate the safety and efficacy of our treatments. We collaborate with leading academic institutions and healthcare professionals to ensure that our research is grounded in the latest scientific advancements.

Our vision extends beyond drug development; we aim to build a supportive community for patients and their families. Through educational initiatives and advocacy efforts, we strive to raise awareness about rare genetic disorders and promote access to essential therapies.

As we continue to grow, we remain focused on our core values: integrity, innovation, and inclusivity. We believe that by fostering a diverse and inclusive workplace, we can drive creativity and enhance our ability to serve patients effectively.

Join us on our journey as we work tirelessly to bring transformative solutions to those affected by rare genetic disorders of obesity.